Clear and cold this Friday morning along California’s north coast, after a night of heavy rain, a bit of hammering hail, and a faded-yellow sunrise, looks like a nice weather-day ahead — shivery as shit, though.
On this peculiar holiday, another sad, hypocritical example of human idiocy — via NPR: ‘Parents of children with severe epilepsy have reported incredible recoveries when their children were given cannabidiol, a derivative of marijuana. The drug, a non-psychoactive compound that occurs naturally in cannabis, has been marketed with epithets like Charlotte’s Web and Haleigh’s Hope.’
(Illustration found here).
Of course, the research presented a ‘grain of salt‘ with the sugar, mainly because ‘…no clinical data on cannabidiol’s safety or efficacy as an anti-epileptic..,’ and only earlier this month, the ‘first studies‘ released on how the whole thing works.
How long has marijuana been available? This is 2015, right?
During just the last couple of years has so many health-related research/studies, whatnot, pointed to the incredible benefits of the varied parts to marijuana — from Alzheimer’s disease, Parkinson, to even helping veterans cope with PTSD, a shitload of good.
Only decades late…
Continuing at NPR:
But for the 261 patients that continued taking cannabidiol, the number of convulsive seizures, called grand mal or tonic-clonic seizures, went down by about half on average.
Devinsky says that some children continued to experience benefits on cannabidiol after the trial ended.
“In the subsequent periods, which are very encouraging, 9 percent of all patients and 13 percent of those with Dravet Syndrome epilepsy were seizure-free. Many have never been seizure-free before,” he says.
It’s one of several papers on cannabidiol being presented this week at the American Epilepsy Society meeting in Philadelphia.
Some patients in Devinsky’s trial also did worse while on cannabidiol, but he thinks there’s no way to tell if it was because of the drug or something else.
He says we won’t know until a full clinical trial has run its course. Without that, the perceived effects of the drug might be a placebo effect or it could be some other confounding factor that hasn’t been caught in the study.
What’s more, a few hundred patients isn’t a lot of patients, and doctors still need to see what will happen when a patient is on cannabidiol for more than a few months.
Even though the results presented at the American Epilepsy Society meeting look encouraging, researchers caution that there’s no promise cannabidiol is really going to work for many of these treatment resistant epilepsy syndromes.
Until there is a full clinical trial done with a placebo-controlled element, Devinsky and others say it’s impossible to tell if cannabidiol is having a real effect on epilepsy.
That takes time and puts parents in a difficult position, he says.
“Parents are desperate and they feel the medical community has failed them, which is true in many cases.”
More of medical in cahoots with crazed-political…anti-ganja goof.